Astrazeneca plc ADR (NASDAQ: AZN) is -7.73% lower on its value in year-to-date trading and has touched a low of $61.24 and a high of $87.68 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AZN stock was last observed hovering at around $71.13 in the last trading session, with the day’s gains setting it 0.61%.
Currently trading at $71.74, the stock is 1.22% and 1.34% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.4 million and changing 0.86% at the moment leaves the stock 1.11% off its SMA200. AZN registered 9.49% gain for a year compared to 6-month gain of 7.75%. The firm has a 50-day simple moving average (SMA 50) of $70.7932 and a 200-day simple moving average (SMA200) of $70.9519.
The stock witnessed a -2.71% loss in the last 1 month and extending the period to 3 months gives it a 10.59%, and is 3.03% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 1.51% over the week and 1.52% over the month.
Astrazeneca plc ADR (AZN) has around 94300 employees, a market worth around $222.49B and $54.98B in sales. Current P/E ratio is 28.82 and Fwd P/E is 14.04. Profit margin for the company is 14.14%. Distance from 52-week low is 17.15% and -18.18% from its 52-week high. The company has generated returns on investments over the last 12 months (11.28%).
The EPS is expected to grow by 10.05% this year.
Astrazeneca plc ADR (AZN) Top Institutional Holders
1509.0 institutions hold shares in Astrazeneca plc ADR (AZN), with institutional investors hold 17.08% of the company’s shares. The shares outstanding are 3.10B, and float is at 3.10B with Short Float at 0.22%. Institutions hold 17.08% of the Float.
The top institutional shareholder in the company is PRICE T ROWE ASSOCIATES INC /MD/ with over 64.94 million shares valued at $5.06 billion. The investor’s holdings represent 4.1788% of the AZN Shares outstanding. As of 2024-06-30, the second largest holder is PRIMECAP MANAGEMENT CO/CA/ with 42.6 million shares valued at $3.32 billion to account for 2.7411 of the shares outstanding. The other top investors are WELLINGTON MANAGEMENT GROUP LLP which holds 40.57 million shares representing 2.6106% and valued at over $3.16 billion, while CAPITAL INTERNATIONAL INVESTORS holds 2.3618 of the shares totaling 36.7 million with a market value of $2.86 billion.
Astrazeneca plc ADR (AZN) Insider Activity
#####
